The observed modifying effect of Th1/Th2 genotypes on the association between EGF and HCC is not surprising, given the well-established interplay of NF-κB and JAK-STAT pathways and cytokine/growth factor signaling in liver regeneration. The gene discussed is EGF; the disease is hepatocellular carcinoma.